Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04046900 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vaginal Microbiota Transplant

Study acronym: MOTIF
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv14
  2. Primary completion date: Sep 30, 2026 to Jan 30, 2027
    • Study completion date: Sep 30, 2026 to Jun 30, 2027
    v13
  3. Primary and study completion dates: Sep 2026 to Sep 30, 2026v12
  4. Primary completion date: Oct 2025 to Sep 2026
    • Study completion date: Apr 2026 to Sep 2026
    • Site contact updated
    v11
  5. Enrollment target: 134 to 62
    • Primary endpoint revised
    • Secondary endpoints: 2 to 3
    • Site contact updated
    v10
Show 8 earlier versionsHide 8 earlier versions
  1. Primary completion date: Dec 2024 to Oct 2025
    • Study completion date: Jun 2025 to Apr 2026
    v9
  2. Primary completion date: Dec 2023 to Dec 2024
    • Study completion date: Jun 2024 to Jun 2025
    v8
  3. Re-verified, no change to tracked fieldsv7
  4. Trial status: Not Yet Recruiting to Recruiting
    • Enrollment target: 126 to 134
    • Start date changed from estimate of Nov 2021 to Apr 22, 2021
    • Site details revised
    v6
  5. Study title shortened, about 2 wordsv5
  6. Eligibility criteria revisedv4
  7. Primary completion date: Jul 2021 to Dec 2023v3 Show 4 more changesShow less
    • Start date: Feb 13, 2020 to Nov 2021
    • Trial status: Recruiting to Not Yet Recruiting
    • Study completion date: Jan 2022 to Jun 2024
    • Site details revised
  8. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2019 to Feb 13, 2020
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized trial of vaginal microbiome transplant vs. saline placebo to restore a Lactobacillus dominant vaginal microbial community in women with recurrent bacterial vaginosis.
Trial Details
NCT Number NCT04046900
Lead Sponsor Douglas Kwon
Conditions
(from sponsor)		 Recurrent Bacterial Vaginosis
Related terms Vaginosis, Bacterial
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov